Skip to main content

Table 1 Study participant’s characteristics at baseline

From: Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)

 

Participants

N = 34

Age, years

12.5 ± 3.7

Male, n (%)

16 (47%)

Female, n (%)

18 (53%)

Weight, kg

48.2 ± 16.7

BMI, kg/m2

20.4 ± 3.8

BMI, percentile

76.8 ± 10.4

Duration of diabetes, years

4.3 ± 2.9

TDD, U/(kg/d)

0.9 ± 0.3

HbA1c, mmol/mol

70 ± 18.6

HbA1c, %

8.6 ± 1.7

Sensor use, n (%)

 RT CGM

6 (18%)

 isCGM

10 (29%)

No Sensor

18 (53%)

  1. All values are shown as mean ± SD, except for gender and sensor use
  2. BMI Body Mass Index, TDD Total daily dose of insulin, SD Standard Deviation, RT-CGM Real time continuous glucose monitoring (Dexcom G5/Guardian Connect), isCGM Intermittent continuous glucose monitoring (Freestyle libre)